We keep you informed about the most recent news and trends on Bioscience Valuation as well as the global healthcare market.

Bioscience Valuation - News

The post-pandemic BioPharma industry in 2021, 4 new KPIs

The BioPharma industry is going through a transition period. The traditional commercial launch model is no longer sustainable, and the pandemic made it redundant. As companies continue to move toward a new model, they must answer a key question…

Pharma companies are becoming increasingly aware of the importance of the continuing scientific education of their employees. If decision makers were to overlook this significant issue, scientists may find it harder than their academic peers to stay uptodate so as to be able to interact well with the broader context. This is immensely required for scientific progress. View these Continued Education-certified talks that are accessible at HS Talks.